Victoza Approved For Use. Should You Take It?
My plans for getting out of town are not going well this year. Because my friend Sandy works in the medical field, she takes continuing medical education (CME) courses here and there and I sometimes tag along. This month, we were going to go to San Francisco for a long weekend. I have friends there and some favorite restaurants, so I was looking forward to it. Well, Sandy quit her job and went back to school, so a long weekend in San Francisco gave way to an overnighter in Louisville. That’s OK. I have a favorite store in southern Indiana and was looking forward to trying out a new restaurant in Louisville. I could hardly wait to hit the road. That would have been last Friday. “Would have been?” Yep. The night before we were to leave, Sandy called. “Have you seen the weather report?” she asked. Good ol’ Mother Nature. Stuck at home after all, I took the opportunity to do a little digging about liraglutide (brand name Victoza), a new drug for Type 2 diabetes that was approved on Jan. 25, 2010, and should be available sometime in March. Victoza is a glucagon-like peptide-1 (GLP-1) agonist, as is exenatide (Byetta). (Byetta has been linked to an increased risk of pancreati Continue reading >>